Hesperadin
CAS No. 422513-13-1
Hesperadin( —— )
Catalog No. M14438 CAS No. 422513-13-1
Hesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 30 | In Stock |
|
5MG | 47 | In Stock |
|
10MG | 69 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 186 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHesperadin
-
NoteResearch use only, not for human use.
-
Brief DescriptionHesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy.
-
DescriptionHesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy, causes mammalian cells to enter anaphase in the presence of monooriented chromosomes; inhibits histone H3 phosphorylation and causes midspindle defects, but does not inhibit APC and separase activation; also markedly reduces the activity of AMPK, Lck, MKK1, MAPKAP-K1, CHK1, and PHK in vitro.
-
In VitroHesperadin (10-100 nM) inhibits the Aurora kinase-1 (TbAUK1)-mediated phosphoryation of trypanosome histone H3 (TbH3) in a dose dependent manner, with an IC50 of 40 nM.Hesperadin (0.01-10 μM; 24 or 48 hours) inhibits growth of bloodstream forms (BF) and procyclic forms (PF) cultures.Hesperadin (100-200 nM; 24-72 hours) alters cell morphology and inhibits cell cycle progression similar to the RNAi knockdown of TbAUK1. Cell Viability Assay Cell Line:M110 cells Concentration:0.01, 0.1, 1, 10 μM Incubation Time:24 hours or 48 hours Result:Inhibiting growth of BF cultures with IC50 of 50 nM, while the inhibition of PF growth required approximately 11-fold more Hesperadin, with IC50 of 550 nM.Cell Cycle Analysis Cell Line:M110 cells Concentration:100, 200 nM Incubation Time:24, 48, 72 hours Result:Had a strong effect on cell growth and mitotic progression at 100-200 nM.
-
In VivoHesperadin (20 mg/kg/d; i.v.) prolongs the survival of xenograft mice via synergistic effect with temozolomide (TMZ). Animal Model:6-week-old female nude mice injected GBM cells Dosage:20 mg/kg/d Administration:I.v. injection Result:Increased the survival of xenograft mice models.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAuroraB(human)|TbAUK1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number422513-13-1
-
Formula Weight516.6544
-
Molecular FormulaC29H32N4O3S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCS(=O)(=O)NC1=CC2=C(C=C1)NC(=C2C(=NC3=CC=C(C=C3)CN4CCCCC4)C5=CC=CC=C5)O
-
Chemical NameEthanesulfonamide, N-[2,3-dihydro-2-oxo-3-[(3Z)-phenyl[[4-(1-piperidinylmethyl)phenyl]amino]methylene]-1H-indol-5-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hauf S, et al. J Cell Biol. 2003 Apr 28;161(2):281-94.
2. Sessa F, et al. Mol Cell. 2005 Apr 29;18(3):379-91.
3. Kapoor TM, et al. Science. 2006 Jan 20;311(5759):388-91.
4. Jetton N, et al. Mol Microbiol. 2009 Apr;72(2):442-58.
molnova catalog
related products
-
BI 831266
BI 831266 is a potent, selective inhibitor of Aurora kinase B (AURKB) with IC50 of binding IC50 of 42 nM.
-
Hesperadin
Hesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy.
-
TAK-901
A multikinase inhibitor with IC50 of 21 nM and 15 nM for Aurora A/TPX2 and Aurora B/INCENP respectively; inhibits 56 kinases(IC50< 100 nM).